Phillips Medisize parent company Molex announced that it agreed to acquire Vectura from a subsidiary of cigarette maker Philip Morris. Vectura designs and develops devices and formulations for inhaled drug delivery. Philip Morris paid $1.2 billion for the UK-based company in 2021 as part of its “Beyond Nicotine” effort to phase out cigarettes and develop […]
Phillips-Medisize
Phillips-Medisize, GlucoModicum partner on needle-free CGM
Molex company Phillips-Medisize today announced a partnership with GlucoModicum to design a new continuous glucose monitor (CGM). The companies teamed up to design and eventually commercialize a proprietary, non-invasive, wearable CGM device. They aim to remove the technology and patient-care roadblocks that exist within continuous glucose monitoring. Phillips-Medisize develops drug delivery, in vitro diagnostic and […]
Phillips-Medisize unveils new disposable injector pen
Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector. Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry. The company plans to display the pen at […]
6 drug delivery innovations you need to know
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops. Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies. More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With […]
Phillips-Medisize expands its global manufacturing capacity
Phillips-Medisize announced today that it expanded its global manufacturing capacity through several collaborations and internal initiatives. Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world. Get the full story […]
Phillips-Medisize unveils Aria smart autoinjector
Phillips-Medisize today unveiled the Aria smart autoinjector platform designed to elevate patient care and reduce environmental impact. Hudson, Wis.–based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes. The company designed the Aria autoinjector […]
Most pharma executives see digital drug delivery as important, Molex says
A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery. Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 pharmaceutical professionals who are stakeholders in a range of digital drug delivery devices, according to a news release. Those devices are designed to provide a […]
Phillips-Medisize, Subcuject team on wearable osmotic bolus injector
Phillips-Medisize announced today that it is collaborating with Subcuject to bring a wearable bolus injector to market. Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the on-body delivery system technology that is based on osmosis is now available for the next stage of drug-specific wearable injector solution after Subcuject filed for […]
Molex taps former Ecolab SVP to run its medical business, including Phillips-Medisize
Paul Chaffin — most recently SVP of enterprise initiatives at Ecolab — has become SVP in charge of Molex’s Medical and Pharmaceutical Solutions division, including contract manufacturing giant Phillips-Medisize. Chaffin will report to Molex CEO Joe Nelligan and will be a member of the company’s Global Leadership Team. Get the full story on our sister […]
Phillips-Medisize expands Denmark site
Phillips-Medisize, a Molex company, announced today that it has expanded its Global Innovation and Development site in Struer, Denmark. The Hudson, Wis.–based company — a contract manufacturing giant in the drug delivery device space — plans to open a dedicated Manufacturing Development and Clinical build unit in Stuer by the second quarter of 2020. Get […]